sNDA submitted to U.S. FDA for Seroquel for bipolar depression treatment

AstraZeneca (AZN) has submitted a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) to seek approval for a new indication for Seroquel (quetiapine fumarate) for [...]